paclitaxel has been researched along with Epistaxis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iida, S; Iwamoto, M; Kurita, T; Saegusa, H; Takei, H; Uchida, E; Yamashita, K; Yanagihara, K | 1 |
| Cyjon, A; Evron, E; Kovel, S; Sella, A; Yachnin, A; Yarom, N | 1 |
| Benedetti Panici, P; Caradio, F; Marchetti, C; Perniola, G; Tomao, F | 1 |
1 trial(s) available for paclitaxel and Epistaxis
| Article | Year |
|---|---|
Epistaxis during treatment with paclitaxel.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Drug Administration Schedule; Epistaxis; Female; Humans; Incidence; Middle Aged; Paclitaxel; Platelet Count; Prospective Studies; Severity of Illness Index | 2009 |
2 other study(ies) available for paclitaxel and Epistaxis
| Article | Year |
|---|---|
Grade 4 epistaxis in a woman with metastatic breast cancer treated with bevacizumab: a case report.
Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast Neoplasms; Carcinoma, Ductal, Breast; Epistaxis; Female; Humans; Neoplasm Grading; Neoplasm Metastasis; Paclitaxel; Severity of Illness Index | 2014 |
Epistaxis in weekly paclitaxel regimen: Is it really related to schedule?
Topics: Antineoplastic Agents, Phytogenic; Drug Administration Schedule; Epistaxis; Humans; Paclitaxel; Platelet Count; Severity of Illness Index | 2011 |